For midwives
Presentations from the 2016 Cumbria Conference
Dr Sarah Vause from St Mary’s Hospital in Manchester talks about identifying cardiomyopathy in patients who are pregnant.
Maternal Deaths from Cardiomyopathies – lessons learnt
Dr Adrian Brodison, Consultant Cardiologist and Clinical Lead for Cardiology, at University of Hospitals Morecambe Bay Foundation Trust, talks about the effects of cardiomyopathy on pregnancy.
Physiology clinical examination and echocardiography in normal pregnancy
References
European Society of Cardiology Guidelines
ESC Clinical Practice Guidelines on the management of cardiovascular disease during pregnancy.
ESC Guidelines on the management of cardiovascular diseases during pregnancy. The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
AL Caforio et al
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society or Cardiology Working group on peripartum cardiomyopathy.
K Sliwa et al
European Cardiomyopathy Pilot Registry: EURObservational Research Programme of the European Society of Cardiology.
P Elliott et al
ESC Textbook of Cardiovascular Medicine, containing a chapter on pregnancy and heart disease.
Other research and resources
A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.
D Hilfiker-Kleiner et al
Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy.
A Gulati et al JAMA (2013); 309(9):896-908
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy.
IS Patten et al
The Carvedilol Hibernation Reversible Ischaemia Trial: Marker of Success (CHRISTMAS).
JGF Cleland et al
Clinical Outcomes for Peripartum Cardiomyopathy in North America: Results of the IPAC Study (Investigations of Pregnancy-Associated Cardiomyopathy).
DM McNamara et al
Clinical Profile and Predictors of Complications in Peripartum Cardiomyopathy.
S Goland et al
Dual Coronary Emboli in Peripartum Cardiomyopathy.
LC Box, V Hanak & JG Arciniegas
National Perinatal Epidemiology Unit, featuring the results of the MBRRACE-UK: Mothers and Babies Reducing Risk through Audits and Confidential Enquiries across the UK report.
Pregnancy-associated cardiomyopathy: clinical characteristics and comparison between early and late presentation.
U Elkayam et alCirculation (2005); 111:2050
The relationship between pre-eclampsia and Peripartum cardiomyopathy: a systematic review and meta-analysis.
N Bello, IS Hurtado Rendon, Z AranyJACC (2013); Vol 62, Issue 18
Reports on Confidential Enquiries into Maternal Deaths: management strategies based on trends in maternal cardiac deaths over 30 years.
S Malhotra & SM YentisInt J Obstet Anesth (2006); 15(3):223-6